Insider Trading June 24, 2026 05:11 PM

VeriSign Executive Chairman D. James Bidzos Executes $820,140 Stock Sale

Insider transaction follows strong Q1 2026 earnings beat, as company navigates near-term valuation dynamics.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
VRSN

D. James Bidzos, serving as Executive Chairman, President, and CEO of VeriSign Inc. (NASDAQ: VRSN), executed a series of sales totaling $820,140 in company equity on June 23, 2026. The transaction involved the disposition of 3,300 shares of common stock, with execution prices ranging between $246.10 and $250.00 per share. This insider activity occurs against a backdrop of recent financial results that surpassed consensus estimates, though the broader market context presents mixed signals regarding short-term price action and long-term valuation assessments.

VeriSign Executive Chairman D. James Bidzos Executes $820,140 Stock Sale
VRSN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Insider divestment: D. James Bidzos sold 3,300 shares for $820,140 on June 23, 2026, with execution prices between $246.10 and $250.00.
  • Financial performance: VeriSign reported first-quarter 2026 earnings that exceeded analyst forecasts, with EPS of $2.34 against a $2.31 expectation, and revenue of $429 million versus a $425.16 million consensus.
  • Market context: The stock currently trades at $252.11, reflecting a near 7% decline over the past week, though analytical assessments suggest the company may remain undervalued relative to fair value metrics.

D. James Bidzos, holding the roles of Executive Chairman, President, and CEO at VeriSign Inc., completed a significant divestment of company equity on June 23, 2026. The transaction resulted in proceeds of $820,140, derived from the sale of 3,300 shares of VeriSign common stock. Market data indicates that these shares were liquidated across multiple execution points, with prices varying between $246.10 and $250.00 per share. Following the completion of these sales, Mr. Bidzos retains a direct holding of 429,439.0301 shares of VeriSign common stock.

Key Points:

  • Insider divestment: D. James Bidzos sold 3,300 shares for $820,140 on June 23, 2026, with execution prices between $246.10 and $250.00.
  • Financial performance: VeriSign reported first-quarter 2026 earnings that exceeded analyst forecasts, with EPS of $2.34 against a $2.31 expectation, and revenue of $429 million versus a $425.16 million consensus.
  • Market context: The stock currently trades at $252.11, reflecting a near 7% decline over the past week, though analytical assessments suggest the company may remain undervalued relative to fair value metrics.

Risks and Uncertainties:

  • Short-term price volatility: The recent 7% weekly decline in share price introduces near-term uncertainty, despite the company’s fundamental outperformance in the latest reporting period.
  • Valuation divergence: While the current market price of $252.11 suggests a discount relative to fair value assessments, the lack of detailed price movement data following the earnings announcement leaves the immediate market reaction unclear.

VeriSign’s financial results for the first quarter of 2026 demonstrated a clear outperformance against market expectations. The company reported earnings per share of $2.34, surpassing the consensus forecast of $2.31. Top-line revenue also exceeded projections, reaching $429 million against an expected $425.16 million. These results indicate a robust operational performance that contrasts with the recent downward pressure on the stock price. No analyst upgrades or downgrades were cited in conjunction with these financial results, leaving the fundamental outlook based solely on the reported figures. Investors monitoring the company’s financial health and market position should consider the divergence between the strong earnings beat and the recent share price depreciation. The insider transaction by Mr. Bidzos, while substantial in absolute terms, represents a fraction of his remaining holdings and does not necessarily signal a change in long-term confidence in the company’s strategic direction.

Risks

  • Short-term price volatility: The recent 7% weekly decline in share price introduces near-term uncertainty, despite the company’s fundamental outperformance in the latest reporting period.
  • Valuation divergence: While the current market price of $252.11 suggests a discount relative to fair value assessments, the lack of detailed price movement data following the earnings announcement leaves the immediate market reaction unclear.

More from Insider Trading

BioCardia Director Simon Stertzer Executes $103,584 Share Accumulation Amid Regulatory Milestones Jun 24, 2026 Ibotta CEO Bryan Leach Offloads $461K in Shares Under Pre-Arranged Trading Plan Jun 24, 2026 Sunstone Hotel Investors CIO Robert Springer Disposes of $1.04M Stake Jun 24, 2026 Hershey Trust Co. Liquidates $5.3M in Hershey Stock Amid Leadership and Rating Shifts Jun 24, 2026 Asana Executive Katie Colendich Offloads Shares Amidst Ongoing Stock Decline Jun 24, 2026